- Home
- GIPR vs CPHI Comparison
GIPR vs CPHI Comparison
Compare GIPR & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIPR
- CPHI
- Stock Information
- Founded
- GIPR 2015
- CPHI N/A
- Country
- GIPR United States
- CPHI China
- Employees
- GIPR N/A
- CPHI N/A
- Industry
- GIPR Real Estate Investment Trusts
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- GIPR Real Estate
- CPHI Health Care
- Exchange
- GIPR Nasdaq
- CPHI Nasdaq
- Market Cap
- GIPR 6.4M
- CPHI 5.8M
- IPO Year
- GIPR 2021
- CPHI N/A
- Fundamental
- Price
- GIPR $1.30
- CPHI $1.71
- Analyst Decision
- GIPR
- CPHI
- Analyst Count
- GIPR 0
- CPHI 0
- Target Price
- GIPR N/A
- CPHI N/A
- AVG Volume (30 Days)
- GIPR 1.2M
- CPHI 11.4K
- Earning Date
- GIPR 11-14-2025
- CPHI 11-13-2025
- Dividend Yield
- GIPR N/A
- CPHI N/A
- EPS Growth
- GIPR N/A
- CPHI N/A
- EPS
- GIPR N/A
- CPHI N/A
- Revenue
- GIPR $9,884,093.00
- CPHI $4,396,201.00
- Revenue This Year
- GIPR $1.12
- CPHI N/A
- Revenue Next Year
- GIPR $0.52
- CPHI N/A
- P/E Ratio
- GIPR N/A
- CPHI N/A
- Revenue Growth
- GIPR 2.33
- CPHI N/A
- 52 Week Low
- GIPR $0.78
- CPHI $1.20
- 52 Week High
- GIPR $2.14
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- GIPR 47.09
- CPHI 43.31
- Support Level
- GIPR $1.24
- CPHI $1.64
- Resistance Level
- GIPR $1.88
- CPHI $1.85
- Average True Range (ATR)
- GIPR 0.22
- CPHI 0.08
- MACD
- GIPR -0.04
- CPHI -0.02
- Stochastic Oscillator
- GIPR 9.88
- CPHI 31.03
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.